|
FGD6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63413726994577E-12 |
| Normal-vs-Stage2 |
1.73401999999934E-05 |
| Normal-vs-Stage3 |
4.60786964140425E-12 |
| Normal-vs-Stage4 |
4.41859882016615E-11 |
| Stage1-vs-Stage2 |
9.897800E-01 |
| Stage1-vs-Stage3 |
3.099800E-01 |
| Stage1-vs-Stage4 |
2.748200E-02 |
| Stage2-vs-Stage3 |
5.228400E-01 |
| Stage2-vs-Stage4 |
1.082770E-01 |
| Stage3-vs-Stage4 |
1.691020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.216880E-03 |
| Normal-vs-Asian |
1.544040E-02 |
| Caucasian-vs-AfricanAmerican |
1.691700E-02 |
| Caucasian-vs-Asian |
2.633800E-01 |
| AfricanAmerican-vs-Asian |
5.287500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62470037423645E-12 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
4.840400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.657900E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-15 |
| Normal-vs-Age(81-100Yrs) |
1.332300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.368400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.747400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.083630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.247400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.237500E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.358200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.019500E-04 |
| Normal-vs-Grade 2 |
6.10622663543836E-15 |
| Normal-vs-Grade 3 |
3.66373598126302E-15 |
| Normal-vs-Grade 4 |
1.50640000473601E-09 |
| Grade 1-vs-Grade 2 |
6.612400E-01 |
| Grade 1-vs-Grade 3 |
6.381800E-01 |
| Grade 1-vs-Grade 4 |
1.019250E-01 |
| Grade 2-vs-Grade 3 |
9.867000E-01 |
| Grade 2-vs-Grade 4 |
1.015960E-01 |
| Grade 3-vs-Grade 4 |
9.790400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.10782519111308E-15 |
| Normal-vs-ccB subtype |
1.64224189802553E-12 |
| ccA subtype-vs-ccB subtype |
1.134380E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
5.173500E-04 |
| N0-vs-N1 |
1.687510E-02 |
|
|
